NGS-31711-30881
1 vaccination
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 363 / AL
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-03-01
Registered in v-safe
- 2021-05-13
-
2022-02-08
Survey response — 12 months, dose 1MedDRA: Sinus disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bad sinusesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-24
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 1
Symptoms: Bad sinuses
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release